3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gastrointestinal
1
Conditions
Lung Neoplasms
5
Prostatic Neoplasms
2
Breast Neoplasms
2
Stomach Neoplasms
1
Sarcoma
1
Pseudomyxoma Peritonei
1
Paranasal Sinus Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Mouth Neoplasms
1
Mesothelioma, Malignant
1
Maxillary Sinus Neoplasms
1
Lymphoma
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Fasting
1
Esophageal Neoplasms
1
Disease
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cigarette Smoking-Related Carcinoma
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Appendiceal Neoplasms
1
Interventions
pembrolizumab
39
Nivolumab
13
Cisplatin
12
Paclitaxel
11
Docetaxel
11
Carboplatin
10
atezolizumab
9
Trastuzumab
9
Gemcitabine
9
Cyclophosphamide
8
fludarabine
7
Bevacizumab
7
aldesleukin
6
durvalumab
5
Taxes
5
Oxaliplatin
5
Magnetic Resonance Spectroscopy
5
Leucovorin
5
Irinotecan
5
Fluorouracil
5
130-nm albumin-bound paclitaxel
5
avelumab
4
Specimen Handling
4
Psychiatric Rehabilitation
4
Ipilimumab
4
Drug Therapy
4
Cetuximab
4
Capecitabine
4
Albumin-Bound Paclitaxel
4
tislelizumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Referral and Consultation
×
Thoracic
×
Clear all
NCT03102229
2026-04-13
RAMPART
Montefiore Medical Center
Phase NA
Completed
40 enrolled